{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:38:23Z","timestamp":1788053903141,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"FSE (Fundo Social Europeu), Uni\u00e3o Europeia"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ijpharm.2015.05.021","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T17:23:35Z","timestamp":1431451415000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Direct nose-to-brain delivery of lamotrigine following intranasal administration to mice"],"prefix":"10.1016","volume":"490","author":[{"given":"Ana","family":"Serralheiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Fortuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00edlcar","family":"Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2015.05.021_bib0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/17425247.2014.945416","article-title":"Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy","volume":"12","author":"Alam","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.epilep.2013.01.001","article-title":"Pharmacoresistant epilepsy: definition and explanation","volume":"1","author":"Alexopoulos","year":"2013","journal-title":"Epileptology"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0015","first-page":"39","article-title":"Formulation and evaluation of sumatriptan succinate nasal in-situ gel using fulvic acid as novel permeation enhancer","volume":"2","author":"Badgujar","year":"2010","journal-title":"Int. J. Pharm. Res. Dev."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/10611860802382777","article-title":"Delivery of testosterone to the brain by intranasal administration: comparison to intravenous testosterone","volume":"17","author":"Banks","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/1061186021000038346","article-title":"Drug targeting to the brain: transfer of picolinic acid along the olfactory pathways","volume":"10","author":"Bergstr\u00f6m","year":"2002","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0030","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/17425255.2.6.1009","article-title":"Pharmacokinetics: toxicology and safety of lamotrigine in epilepsy","volume":"2","author":"Biton","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1528-1167.2010.02520.x","article-title":"Relationship between adverse effects of antiepileptic drugs number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy","volume":"51","author":"Canevini","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0040","series-title":"Caracteriza\u00e7\u00e3o neurofarmacocin\u00e9tica da lamotrigina em ratos","author":"Castel-Branco","year":"2002"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0045","first-page":"402","article-title":"Formulation and in vitro characterization of intranasal mucoadhesive microspheres of lamotrigine using chitosan by gluteraldehyde cross linking","volume":"4","author":"Dave","year":"2013","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0050","unstructured":"European Medicines Agency, 2011. Guideline on bioanalytical method validation http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0055","unstructured":"European Parliament, Council of the European Union, 2010. Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientifc purposes. Off. J. Eur. Union. 276, 33\u201379."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2007.00992.x","article-title":"Refractory epilepsy: clinical overview","volume":"48","author":"French","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2165\/00003495-199346010-00009","article-title":"Lamotrigine \u2013 a review of its pharmacological properties and clinical efficacy in epilepsy","volume":"46","author":"Goa","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/187221108783331429","article-title":"Recent patents review on intranasal administration for CNS drug delivery","volume":"2","author":"Jogani","year":"2008","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","article-title":"Quantitative analysis of drug delivery to the brain via nasal route","volume":"189","author":"Kozlovskaya","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0080","series-title":"Drug delivery to the Brain \u2013 Physiological concepts, methodologies and approaches, AAPS Advances in the Pharmaceutical Sciences Series 10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/978-1-4614-9105-7_14","article-title":"Intranasal drug delivery to the brain","author":"Lochhead","year":"2014"},{"issue":"Suppl. 1","key":"10.1016\/j.ijpharm.2015.05.021_bib0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1528-1167.2007.00993.x","article-title":"Drug transporters in the epileptic brain","volume":"48","author":"L\u00f6scher","year":"2007","journal-title":"Epilepsia."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0090","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.neuropharm.2008.08.032","article-title":"Several major antiepileptic drugs are substrates for human P-glycoprotein","volume":"55","author":"Luna-Tort\u00f3s","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0095","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2217\/pgs.10.126","article-title":"Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches","volume":"11","author":"Potschka","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pharmthera.2009.10.004","article-title":"Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach","volume":"125","author":"Potschka","year":"2010","journal-title":"Pharmacolo. Ther."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0105","series-title":"Handbook of Clinical Neurology \u2013 Epilepsy Part II: Treatment","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/B978-0-444-52899-5.00025-3","article-title":"Pharmacoresistance","author":"Potschka","year":"2012"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(02)00423-8","article-title":"P-Glycoprotein-mediated efflux of phenobarbital lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats","volume":"327","author":"Potschka","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0115","first-page":"825","article-title":"Safety and efficacy of lamotrigine in older adults with epilepsy and co-morbid depressive symptoms","volume":"1","author":"Schiller","year":"2009","journal-title":"Clin. Med. Ther."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0120","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1528-1167.2005.54904.x","article-title":"Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms","volume":"46","author":"Schmidt","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0125","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jbm.820060609","article-title":"Artificial Skin I. Preparation and properties of pluronic F-127 gels for treatment of burns","volume":"6","author":"Schmolka","year":"1972","journal-title":"J. Biomed. Mater. Res"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejps.2014.04.019","article-title":"Intranasal administration of carbamazepine to mice: a direct delivery pathway for brain targeting","volume":"60","author":"Serralheiro","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0135","series-title":"Nasal Physiology and Pathophysiology of Nasal Disorders","first-page":"191","article-title":"Nose as route for drug delivery","author":"Serralheiro","year":"2013"},{"issue":"Suppl. 3","key":"10.1016\/j.ijpharm.2015.05.021_bib0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1528-1167.2009.02042.x","article-title":"Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959\u20132009","volume":"50","author":"Shorvon","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0145","first-page":"168","article-title":"Mucoadhesive in situ gels as nasal drug delivery systems: an overview","volume":"7","author":"Swamy","year":"2012","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0150","unstructured":"US Food and Drug Administration, 2001. Guidance for industry: Bioanalytical method validation. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm070107.pdf."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0155","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/sj.bjp.0703337","article-title":"Comparison of serum: cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine","volume":"130","author":"Walker","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(03)00341-7","article-title":"Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats","volume":"263","author":"Wang","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"Suppl. 2","key":"10.1016\/j.ijpharm.2015.05.021_bib0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/epi.12185","article-title":"Design of innovative therapeutics for pharmacoresistant epilepsy: challenges and needs","volume":"54","author":"Weaver","year":"2013","journal-title":"Epilepsia"},{"issue":"Suppl. 2","key":"10.1016\/j.ijpharm.2015.05.021_bib0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/epi.12191","article-title":"Pharmacoresistant epilepsy: unmet needs in solving the puzzle(s)","volume":"54","author":"Weaver","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.ijpharm.2015.05.021_bib0175","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.addr.2011.12.003","article-title":"The transport of antiepileptic drugs by P-glycoprotein","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517315004408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517315004408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T17:27:14Z","timestamp":1537637234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517315004408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0378517315004408"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.05.021","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct nose-to-brain delivery of lamotrigine following intranasal administration to mice","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}